Dr. Reddy’s Laboratories Limited Q3 2025 Financial Results

Dr. Reddy’s Laboratories Limited has submitted its unaudited financial results for the quarter and half-year ended September 30, 2025, as required by Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. The results were published in the Financial Express and Andhra Prabha on October 25, 2025. The filing includes the necessary documentation and signatures, with K Randhir Singh, the Company Secretary, Compliance Officer & Head-CSR, authorizing the submission. This filing is a routine disclosure of financial performance and does not indicate any significant corporate changes or events.